New drug interventions are needed to biologically alter disease processes within individuals in increasingly individualized and targeted ways. New drugs are developed in a variety of old and new ways--some derived from natural products and others synthesized in the laboratory by chemists. Translational researchers must work with clinicians and regulatory agencies to ensure the safety and efficacy of new drugs.
